Eldepryl

Active Ingredient(s): Selegiline
FDA Approved: * May 15, 1996
Pharm Company: * SOMERSET
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Eldepryl Overview

Selegiline, also known as L-deprenyl, is a substituted phenethylamine. At normal clinical doses, it is a selective irreversible MAO-B inhibitor. In larger doses it loses its specificity and also inhibits MAO-A. It is available in pill form under many brand names[1] and is used to reduce symptoms in early-stage Parkinson's disease. A transdermal patch (brand name, Emsam) is used to treat depression. .mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .to...

Read more Eldepryl Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Selegiline

Recent Eldepryl Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Eldepryl: (3 results)

Sorted by National Drug Code

• 39506-011 Eldepryl 5 mg Oral Tablet by Somerset Pharmaceuticals Inc.
• 39506-022 Eldepryl 5 mg Oral Capsule by Somerset Pharmaceuticals Inc.
• 49502-420 Eldepryl 5 mg Oral Capsule by Mylan Specialty

Other drugs which contain Selegiline or a similar ingredient: (4 results)

• CARBEX Selegiline
• EMSAM Selegiline8 discussions
• SELEGILINE 3 discussions
• ZELAPAR Selegiline2 discussions